Other spirochaetal infection, Other specified spirochaetal infections[MORBUS LYME]
1048A (2000400805)
Meningitis (in) Lyme disease
G01*A69.2 (2000502068)
Arthritis in Lyme disease
M01.2*A69.2 (2000502987)
Tick-borne viral encephalitis, unspecified
A84.9 (45571447)
Lyme disease
A69.2 (45595594)
Erythema in other diseases classified elsewhere and Lyme disease
L54.8*A69.2 (2000504056)
SMOKING - SMOKE2: no - SMOKE3: former - SMOKE5: former
SMOKING-2-2-4 (2002330109)
SMOKING - SMOKE2: no - SMOKE3: never - SMOKE5: never
SMOKING-2-3-5 (2002330114)
SMOKING - SMOKE2: yes - SMOKE3: current - SMOKE5: Unspecified
SMOKING-1-1-0 (2002330116)
Relapsing fever, unspecified
A68.9 (45537741)
Arthritis in Lyme disease
M01.2 (45567391)
Polyneuropathy (in) Lyme disease
G63.0*A69.2 (2000502178)
Submitting image material and/or investigation material to patient
XX9CW (2001311045)
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
307 (2001600266)
Neurological infection other
N73 (2002000778)
SMOKING - SMOKE2: no - SMOKE3: former - SMOKE5: Unspecified
SMOKING-2-2-0 (2002330110)
SMOKING - SMOKE2: no - SMOKE3: Unspecified - SMOKE5: Unspecified
SMOKING-2-0-0 (2002330112)
SMOKING - SMOKE2: no - SMOKE3: never - SMOKE5: Unspecified
SMOKING-2-3-0 (2002330113)
probenecid; oral
M04AB01 (21604136)
IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
2470-3 (3007798)
Albumin in CSF/Albumin in Serum or Plasma
1756-6 (3013247)
Lymphocytes/Leukocytes in Cerebral spinal fluid
26479-6 (3020951)
Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
17303-9 (3035929)
Granulocytes/Leukocytes in Cerebral spinal fluid
33963-0 (3042847)
Body height measure
50373000 (4177340)
Body mass index
60621009 (4245997)
European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
69927-2 (42868418)
Other tick-borne viral encephalitis
A84.8 (45532856)
Unspecified viral encephalitis
A86 (45542542)
Spirochaetal infection, unspecified
A69.9 (45585931)
Relapsing fever, unspecified
0879X (2000400724)
Toothache NOS
K08.80 (2000502799)
Extensive MRI examination of brain with high intensity magnet
AA1CG (2001300116)
Very extensive MRI examination of brain with high intensity magnet
AA1DG (2001300120)
Ultrasound measurement of residual urine
KC1EE (2001305918)
Occupational therapy
R4120 (2001310234)
Noninvasive ventilation
WX725 (2001310828)
Diabetes, insulin-treated
103 (2001600103)
Removal of foreign body from under the skin
SPAT1152 (2001700253)
Pap smear
SPAT1193 (2001700294)
Skin injury other
S19 (2002000984)
Scabies/other acariasis
S72 (2002001036)
Pediculosis/skin infestation other
S73 (2002001037)
Diabetes insulin dependent
T89 (2002001130)
potassium chloride; oral
A12BA01 (21600877)
hydrocortisone and antiinfectives
S01CA03 (21603654)
risperidone; oral, parenteral
N05AX08 (21604559)
Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
18243-6 (3002823)
IgG [Mass/volume] in Cerebral spinal fluid
2464-6 (3007368)
Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5013-8 (3008733)
Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
12480-0 (3009991)
Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
22126-7 (3010380)
Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5257-1 (3010521)
Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
22118-4 (3011166)
FEV1/FVC
19926-5 (3011505)
Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
29662-4 (3012220)
Varicella zoster virus Ab [Titer] in Serum
21594-7 (3014148)
Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
22133-3 (3014973)
Differential panel - Cerebral spinal fluid
29584-0 (3016018)
Leukocytes [#/volume] in Cerebral spinal fluid
26465-5 (3016543)
Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
21598-8 (3016894)
Bacteria identified in Cerebral spinal fluid by Culture
606-4 (3016914)
Protein [Mass/volume] in Cerebral spinal fluid
2880-3 (3019473)
Glucose [Moles/volume] in Cerebral spinal fluid
14744-7 (3020044)
Forced vital capacity [Volume] Respiratory system
19870-5 (3020158)
Varicella zoster virus IgG Ab [Units/volume] in Serum
8047-3 (3022575)
Appearance of Cerebral spinal fluid
10333-3 (3023410)
Albumin [Mass/volume] in Cerebral spinal fluid
1746-7 (3024474)
Erythrocytes [#/volume] in Cerebral spinal fluid
26454-9 (3027475)
Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
5253-0 (3027545)
Lactate [Moles/volume] in Capillary blood
19239-3 (3028271)
Herpes simplex virus Ab [Presence] in Serum
22339-6 (3028679)
Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
49615-8 (3030429)
Mononuclear cells/Leukocytes in Cerebral spinal fluid
26492-9 (3033306)
Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
41602-4 (3033386)
Lactate [Moles/volume] in Cerebral spinal fluid
2520-5 (3035999)
Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
42991-0 (3037677)
Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
40729-6 (3041145)
Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
44506-4 (3043525)
Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
41150-4 (3044212)
Cell count panel - Cerebral spinal fluid
34563-7 (3044290)
Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
33942-4 (3046896)
Cerebrospinal fluid IgG ratio and IgG index
1324000 (4027681)
Immunohistochemistry procedure
117617002 (4035726)
Venereal disease screening
171128005 (4064905)
Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
56764-4 (40759883)
Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
58755-0 (40761849)
Uroflowmetry
44856007 (4261340)
European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
69923-1 (42868414)
European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
69924-9 (42868415)
European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
69926-4 (42868417)
Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
69930-6 (42868421)
C reactive protein [Mass/volume] in Blood by High sensitivity method
71426-1 (42870365)
CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
74917-6 (44816808)
Rash and other nonspecific skin eruption
R21 (45553721)
Multiple papillomata and wet crab yaws
A66.1 (45556914)
Encephalitis, myelitis and encephalomyelitis, unspecified
G04.9 (45562073)
Congestive heart failure
I50.0 (45567179)
Erythematous condition, unspecified
L53.9 (45577042)
Need for immunization against influenza
Z25.1 (45581017)
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
R29.8 (45587505)
Other dermatitis
L30 (45591633)
Contact with and exposure to pediculosis, acariasis and other infestations
Z20.7 (45609915)
Borrelia burgdorferi IgM Ab [Units/volume] in Serum
7818-8 (3008230)
amoxicillin; oral, parenteral
J01CA04 (21602823)
Borrelia burgdorferi IgG Ab [Units/volume] in Serum
7817-0 (3016888)
Infectious Disease
44 (38004484)
Insect bite/sting
S12 (2002000977)
doxycycline; oral, parenteral
J01AA02 (21602800)
Bitten or stung by nonvenomous insect and other nonvenomous arthropods
W57 (45756308)
Skin symptom/complaint other
S29 (2002000993)
encephalitis, tick borne, inactivated, whole virus
J07BA01 (21601331)
Bell palsy
G51.0 (45571815)
Lumbar puncture
TAB00 (2001300538)
Taking care of patient’s/customer’s hygiene
SPAT1137 (2001700238)
Skin texture symptom/complaint
S21 (2002000986)
Dermatitis, unspecified
L30.9 (45572271)
Skin Pathology biopsy report
65754-4 (40768443)
Fever, unspecified
R50.9 (45582716)
Limited function/disability NOS
A28 (2002000162)
colecalciferol; oral
A11CC05 (21600820)
Observation for other suspected diseases and conditions
Z03.8 (45585798)
Headache
R51.80 (2000503603)
Type 1 diabetes mellitus, With multiple complications
E10.7 (45571655)
Supplier / Service Provider
OMOP5117446 (33004)
Animal/human bite
S13 (2002000978)
Rash localized
S06 (2002000971)
Other and unspecified skin changes
R23.8 (45573020)
Observation for suspected disease or condition, unspecified
Z03.9 (45552062)
Administration of medicine
SPAT1254 (2001700355)
Enterovirus RNA [Presence] in Specimen by NAA with probe detection
29591-5 (3016881)
Case Management Agency
251B00000X (38004193)
Home Visit
OMOP4822459 (581476)
memantine; oral
N06DX01 (21604799)
IgG [Mass/volume] in Serum or Plasma
2465-3 (3005719)
Observation for suspected nervous system disorder
Z03.3 (45609903)
Emergency Room Visit
ER (9203)
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X (38003841)
fusidic acid; ointment
D06AX01 (21602062)
fusidic acid
D09AA02 (21602265)
fluconazole; oral, parenteral
J02AC01 (21603080)
Support of social functional capacity
SPAT1234 (2001700335)
insulin lispro; parenteral
A10AD04 (21600732)
insulin aspart; parenteral
A10AD05 (21600733)
Skin colour change
S08 (2002000973)
insulin lispro; parenteral
A10AB04 (21600718)
insulin lispro; parenteral
A10AC04 (21600726)
insulin aspart; parenteral
A10AB05 (21600719)
Intravenous administration of medicine
SPAT1255 (2001700356)
Allergic urticaria
L50.0 (45581945)
Pharmacy visit
OMOP4822462 (581458)
insulin detemir; parenteral
A10AE05 (21600740)
insulin (beef); parenteral
A10AD02 (21600730)
insulin glargine; parenteral
A10AE04 (21600739)
Observation for other suspected diseases and conditions
Z03.89 (2000503757)
Internal Medicine
11 (38004456)
Actinic keratosis
L57.0 (45591640)
Rheumatoid factor [Units/volume] in Serum or Plasma
11572-5 (3021614)
Bilateral foot X-ray examination
NH3DA (2001308279)
Bilateral hand X-ray examination
ND2DA (2001307619)
Nitrate [Presence] in Urine
32030-9 (3006462)
Type 1 diabetes mellitus, Without complications
E10.9 (45581351)
Paraesthesia of skin
R20.2 (45568120)
Treponema pallidum Ab [Presence] in Serum
22587-0 (3019832)
Inpatient Hospital
21 (8717)
Office Visit
OMOP4822458 (581477)
Nursing episode
950 (44777714)
Pain in joint
M25.5 (45586941)
Cyclic citrullinated peptide Ab [Units/volume] in Serum
53027-9 (3041942)
Local infection of skin and subcutaneous tissue, unspecified
L08.9 (45577027)
Counselling/guidance promoting independent living
SPAT1222 (2001700323)
General Practice
1 (38004446)
Consultation of another employee
SPAT1260 (2001700361)
aPTT in Platelet poor plasma by Coagulation assay
14979-9 (3018677)
Heart failure, unspecified
I50.9 (45576879)
Seborrhoeic keratosis
L82 (45548208)
Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
70058-3 (42868544)
In Home Supportive Care Agency
253Z00000X (38004206)
hydrocortisone
S02BA01 (21605166)
Outpatient Hospital
22 (8756)
Supine thorax X-ray examination
GD1QA (2001303648)
General health counselling
SPAT1312 (2001700413)
hydrocortisone
D07AA02 (21602102)
hydrocortisone butyrate
D07AB02 (21602106)
hydrocortisone buteprate
D07AB11 (21602115)
hydrocortisone aceponate
D07AC16 (21602135)
hydrocortisone
A07EA02 (21600654)
hydrocortisone
C05AA01 (21601608)
Microorganisms panel - Urine sediment
58435-9 (40761536)
HIV 1 and 2 tests - Meaningful Use set
75622-1 (46235355)
C reactive protein [Mass/volume] in Body fluid
16503-5 (3035320)
insulin (human); parenteral
A10AD01 (21600729)
donepezil; oral
N06DA02 (21604795)
Medical observation and evaluation for suspected diseases and conditions, ruled out
Z03 (45552058)
Nuclear Ab [Presence] in Serum
8061-4 (3004616)
Intravenous
ZX120 (2001311495)
olanzapine; oral, parenteral
N05AH03 (21604543)
Urine protein measurement
57378007 (4211845)
combinations of corticosteroids
D07AB30 (21602118)
combinations of corticosteroids
D07XB30 (21602188)
Inpatient Visit
IP (9201)
desonide
D07AB08 (21602112)
hydrocortisone and antiseptics
D07BA04 (21602146)
hydrocortisone
D07XA01 (21602180)
triamcinolone and antiseptics
D07BB03 (21602150)
other antifungals for topical use - combinations; ointment
D01AE20 (21601959)
chlorhexidine, combinations
D08AC52 (21602208)
chlorhexidine
D09AA12 (21602275)
chlorhexidine
S02AA09 (21605155)
chlorhexidine
S03AA04 (21605193)
Lactate [Moles/volume] in Blood
32693-4 (3047181)
Type 1 diabetes mellitus, With ophthalmic complications
E10.3 (45552380)
Atherosclerosis of arteries of extremities
I70.2 (45538421)
azithromycin; oral, parenteral
J01FA10 (21602978)
Erysipelas
A46 (45561706)
Scheduled procedure
ZXD10 (2001311387)
pH of Specimen
17433-4 (3019225)
Type 2 diabetes mellitus, with unspecified complications
E11.8 (45561951)
hydrocortisone; local oral
A01AC03 (21600036)
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 (3043924)
Type 2 diabetes mellitus, with multiple complications
E11.7 (45561950)
Oxygen content in Capillary blood by calculation
64799-0 (40767503)
Outpatient Visit
OP (9202)
Nuclear Ab [Titer] in Serum
29953-7 (3037522)
Treatment of chronic ulcer or burn
SPAT1148 (2001700249)
Person consulting for explanation of investigation findings
Z71.2 (45552100)
Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
19258-3 (3004529)
insulin degludec; parenteral
A10AE06 (43534747)
imidazoles/triazoles in combination with corticosteroids
D01AC20 (21601936)
Gas panel - Central venous blood
97535-9 (1616796)
Rheumatology
66 (38004491)
Examination and observation for other specified reasons
Z04.8 (45552063)
Initiation, adjustment, discontinuation or repetition of medication
SPAT1253 (2001700354)
Cathetrisation of vein
TPH04 (2001309597)
Counselling related to known health issue
SPAT1310 (2001700411)
Other specified chronic obstructive pulmonary disease
J44.8 (45586673)
Bacterial infection, unspecified
A49.9 (45590816)
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
47598-8 (3048816)
Emergency Medicine
93 (38004510)
acetylsalicylic acid; oral, parenteral, rectal
N02BA01 (21604305)
Myeloperoxidase IgG Ab [Units/volume] in Serum
48404-8 (3049804)
Handing over of treatment supplies
SPAT1262 (2001700363)
mometasone
D07AC13 (21602132)
One hour or less
ZXE00 (2001311394)
Dizziness and giddiness
R42 (45568132)
Urticaria, unspecified
L50.9 (45562541)
Emergency Room and Inpatient Visit
ERIP (262)
Care involving use of rehabilitation procedure, unspecified
Z50.9 (45595525)
Cervical spine MRI examination with high intensity magnet
NA1BG (2001306990)
Lactate [Moles/volume] in Venous blood
2519-7 (3008037)
Cellulitis of other parts of limb
L03.1 (45586760)
Thorax X-ray examination
GD1AA (2001303617)
Medical doctor
Z2221 (2001311556)
Tissue Pathology biopsy report
66121-5 (40768804)
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 (3007220)
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 (3013707)
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 (3019902)
Malaise and fatigue
R53 (45553741)
Otolaryngology
4 (38004449)
Telehealth
OMOP5556618 (722455)
Carboxyhemoglobin/Hemoglobin.total in Blood
20563-3 (3023081)
Counselling and guidance which enhance independent living
R2130 (2001310196)
pH of Blood
11558-4 (3010421)
Phadiatop IgE Ab [Units/volume] in Serum
7599-4 (3025443)
Initiation and monitoring of IV fluid therapy
SPAT1083 (2001700184)
valaciclovir; oral
J05AB11 (21603137)
Bicarbonate [Moles/volume] in Venous blood
14627-4 (3027273)
Disease/condition unspecnature/site
A99 (2002000232)
Neutrophil cytoplasmic Ab [Units/volume] in Serum
5128-4 (3001334)
Oxygen [Partial pressure] in Blood
11556-8 (3027315)
Base excess in Blood by calculation
11555-0 (3012501)
Carbon dioxide [Partial pressure] in Blood
11557-6 (3013290)
saccharomyces boulardii; oral
A07FA02 (21600670)
Guidance concerning treatment of rash and skin
SPAT1156 (2001700257)
Pure hypercholesterolaemia
E78.0 (45542771)
Assessment of need for services (elderly/care support)
SPAT1217 (2001700318)
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 (3044938)
Prothrombin time (PT) actual/Normal
5894-1 (3033658)
Acute bronchitis, unspecified
J20.9 (45562445)
Bacteria identified in Blood by Culture
600-7 (3023368)
Glucose [Moles/volume] in Venous blood
39480-9 (3038515)
Acute maxillary sinusitis
J01.0 (45601112)
Methemoglobin/Hemoglobin.total in Blood
2614-6 (3007930)
Other specified counselling
Z71.8 (45581061)
betamethasone
A07EA04 (21600656)
betamethasone
C05AA05 (21601610)
betamethasone
D07AC01 (21602120)
betamethasone
S02BA07 (21605169)
Intravenous general anesthesia
WX404 (2001310807)
Allergy/allergic reaction NOS
A92 (2002000225)
Differential panel, method unspecified - Blood
69738-3 (42870588)
desloratadine; oral
R06AX27 (21603526)
Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
11054-4 (3002109)
Hemoglobin [Mass/volume] in Arterial blood
30313-1 (3002173)
buprenorphine; parenteral, sublingual, transdermal
N02AE01 (21604287)
More than one and less than three hours
ZXE10 (2001311401)
Sampling
SPAT1263 (2001700364)
Hand/finger symptom/complaint
L12 (2002000636)
Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
14685-2 (3009035)
Sodium and Potassium panel [Moles/volume] - Serum or Plasma
34548-8 (3045783)
Counselling and guidance related to nutrition and weight management
SPAT1306 (2001700407)
furosemide; oral, parenteral
C03CA01 (21601518)
Own respiration
WX720 (2001310823)
Natriuretic peptide B [Mass/volume] in Serum or Plasma
30934-4 (3011960)
Type 2 diabetes mellitus, without complications
E11.9 (45561952)
Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
70200-1 (42868674)
Physiotherapy
R4110 (2001310233)
Base excess in Arterial blood by calculation
1925-7 (3003396)
Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
29374-6 (3006999)
Smith extractable nuclear Ab [Units/volume] in Serum
11090-8 (3016921)
Oxygen saturation in Arterial blood
2708-6 (3016502)
Pain in limb
M79.6 (45587063)
Bacteria [#/volume] in Urine by Culture
100906-7 (1761482)
Proteinase 3 Ab [Units/volume] in Serum
6968-2 (3009445)
Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
10886-0 (3005013)
empagliflozin; oral
A10BK03 (1123740)
Pain/tenderness of skin
S01 (2002000966)
Aid fitting and borrowing and monitoring of use
SPAT1230 (2001700331)
Osmolality of Urine
2695-5 (3026782)
Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
17791-5 (3027450)
Monocytes/Leukocytes in Blood
26485-3 (3019069)
Eosinophils/Leukocytes in Blood
26450-7 (3006504)
lactulose; oral
A06AD11 (21600571)
sitagliptin; oral
A10BH01 (21600784)
pH of Arterial blood
2744-1 (3019977)
Oxygen [Partial pressure] in Arterial blood
2703-7 (3027801)
Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
2742-5 (3034780)
Basophils/Leukocytes in Blood
30180-4 (3022096)
Lymphocytes/Leukocytes in Blood
26478-8 (3002030)
Neutrophils/Leukocytes in Blood
26511-6 (3018010)
Physiotherapist
Z3226 (2001311560)
Gonarthrosis [arthrosis of knee]
M17 (45601350)
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 (3020460)
Risk factor NOS
A23 (2002000158)
Other and unspecified abdominal pain
R10.4 (45568113)
Standard MRI examination of brain with high intensity magnet
AA1BG (2001300112)
Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
35333-4 (3036086)
Hyperplasia of prostate
N40 (45563015)
epinephrine
S01EA01 (21603673)
epinephrine; parenteral
C01CA24 (21600303)
Standard cardiac ultrasound examination
FM1AE (2001303278)
Carbon dioxide [Partial pressure] in Arterial blood
2019-8 (3027946)
Gas panel - Arterial blood
24336-0 (3019060)
Short blood count panel - Blood
55429-5 (40758558)
Monocytes [#/volume] in Blood
26484-6 (3001604)
Screening procedure
SPAT1324 (2001700425)
Basophils [#/volume] in Blood
26444-0 (3006315)
Comprehensive monitoring of chronic illness
SPAT1250 (2001700351)
naproxen; oral, rectal
M01AE02 (21603968)
naproxcinod
M01AE18 (40254094)
amoxicillin and beta-lactamase inhibitor; oral, parenteral
J01CR02 (21602863)
Lymphocytes [#/volume] in Blood
26474-7 (3019198)
IgA [Mass/volume] in Serum or Plasma
2458-8 (3007164)
Eosinophils [#/volume] in Blood
26449-9 (3013115)
Chloride [Moles/volume] in Blood
2069-3 (3018572)
Anion gap in Blood by calculation
41276-7 (3039000)
hydrocortisone; oral, parenteral
H02AB09 (21602737)
Lysozyme [Mass/volume] in Serum or Plasma
2589-0 (3012110)
Foot/toe symptom/complaint
L17 (2002000641)
dexamethasone and antiinfectives
S03CA01 (21605206)
Biopsy of skin and subcutaneous tissue
TQX10 (2001310152)
Headache
N01 (2002000720)
Myelocytes/Leukocytes in Blood
26498-6 (3017181)
General and Unspecified, Preventive immunization/medic
A44 (2002000178)
hydroxyzine; oral, parenteral
N05BB01 (21604590)
C reactive protein [Mass/volume] in Capillary blood
48421-2 (3051387)
naproxen and esomeprazole; oral
M01AE52 (40254096)
cetirizine; oral
R06AE07 (21603497)
Promyelocytes/Leukocytes in Blood
26524-9 (3021440)
Chest pain, unspecified
R07.4 (45558450)
Bicarbonate [Moles/volume] in Arterial blood
1960-4 (3008152)
Acute upper respiratory infection, unspecified
J06.9 (45562437)
Phosphate [Moles/volume] in Serum or Plasma
14879-1 (3003458)
Glucose [Moles/volume] in Serum or Plasma
14749-6 (3013826)
prednisone
A07EA03 (21600655)
prednisone; oral
H02AB07 (21602735)
Erythrocytes [Presence] in Urine by Automated
53292-9 (3041096)
spironolactone; oral
C03DA01 (21601534)
Melanocytic naevi
D22 (45595739)
Albumin [Presence] in Urine by Test strip
50949-7 (3029937)
Blasts/Leukocytes in Blood
26446-5 (3025159)
Other minor procedure on skin
TQW99 (2001310150)
Bacteria identified in Urine by Culture
630-4 (3026008)
chloramphenicol
S01AA01 (21603554)
chloramphenicol
S03AA08 (21605197)
pseudoephedrine, combinations; oral
R01BA52 (21603213)
zoster, purified antigen
J07BK03 (1501889)
metformin; oral
A10BA02 (21600747)
prednisolone
S01BA04 (21603621)
prednisolone
S03BA02 (21605202)
Extensive global examination
SPAT1360 (2001700461)
fluticasone, combinations
R01AD58 (43534837)
isosorbide mononitrate; oral
C01DA14 (21600324)
azelastine; nasal
R01AC03 (21605035)
Skin infection other
S76 (2002001040)
No procedures
SPAT1301 (2001700402)
Localized swelling, mass and lump, unspecified
R22.9 (45577788)
oxycodone; oral, parenteral
N02AA05 (21604260)
acrivastine; oral
R06AX18 (21603518)
Oncology Clinic/Center
261QX0200X (38004268)
General and Unspecified, Medication/prescr/renewal
A50 (2002000184)
metoprolol; oral, parenteral
C07AB02 (21601684)
Metamyelocytes/Leukocytes in Blood
28541-1 (3002179)
fluticasone; nasal
R01AD08 (21605050)
fluticasone furoate; nasal
R01AD12 (21605053)
CBC W Ordered Manual Differential panel - Blood
57782-5 (40760892)
Treatment-related counselling outside office
SPAT1249 (2001700350)
quetiapine; oral
N05AH04 (21604544)
Epithelial cells [#/volume] in Urine
30383-4 (3000850)
cefalexin; oral
J01DB01 (21602870)
prednisolone
A07EA01 (21600653)
prednisolone; oral, parenteral
H02AB06 (21602734)
losartan and diuretics
C09DA01 (21601834)
Intubation
WX704 (2001310820)
Atherosclerotic heart disease
I25.1 (45596196)
imiquimod
D06BB10 (21602092)
Neutrophils [#/volume] in Blood by Automated count
751-8 (3013650)
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 (3019800)
Bicarbonate [Moles/volume] in Capillary blood
1961-2 (3015235)
Other seropositive rheumatoid arthritis
M05.8 (45538634)
Urea [Moles/volume] in Serum or Plasma
22664-7 (3020779)
General Surgery
2 (38004447)
Hypothyroidism, unspecified
E03.9 (45537945)
Measurement of difference in extremity lengty with X-ray
NJ3NA (2001308439)
Pure hypercholesterolaemia
E78.01 (2000501514)
Sensorineural hearing loss, bilateral
H90.3 (45576850)
etoricoxib; oral
M01AH05 (21603996)
Albumin [Mass/volume] in Serum or Plasma
1751-7 (3024561)
Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 (40763086)
Assessment of need for rehabilitation and/or rehabilitation plan
SPAT1220 (2001700321)
Laboratory Visit
OMOP4822461 (32036)
Lipid panel - Serum or Plasma
100898-6 (1761868)
Gynecological ultrasound examination as part of clinical examination
LX1AE (2001306815)
sumatriptan; nasal, oral, parenteral, rectal
N02CC01 (21604376)
Arthrocentesis, unspecified region, unspecified region
TNX10 (2001308560)
Examination for driving licence
Z02.4 (45552056)
EKG study
11524-6 (3013512)
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 (3026910)
acetylsalicylic acid; oral
B01AC06 (21600991)
Need for immunization against other specified single viral diseases
Z25.8 (45547296)
Granulocytes [#/volume] in Blood
30394-1 (3035715)
Specific gravity of Urine by Refractometry
5810-7 (3019150)
estradiol; nasal, oral, parenteral, rectal, transdermal, vaginal
G03CA03 (21602517)
Periodontal treatment by dental hygienist, extensive
SDE03 (2001310351)
Health maint/preventive medicine
A98 (2002000231)
zolpidem; oral
N05CF02 (21604655)
Sedation and analgesia
WX002 (2001310758)
Panorama tomography of teeth and jaws or similar X-ray examination
EB1HA (2001301913)
Low back pain
M54.5 (45553207)
cromoglicic acid
S01GX01 (21605085)
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 (46236098)
Gastro-oesophageal reflux disease
K21 (45586708)
dexamethasone
S03BA01 (21605201)
dexamethasone
S01BA01 (21603618)
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 (3029287)
ibuprofen
R02AX02 (1588667)
ibuprofen; oral, parenteral, rectal
M01AE01 (21603967)
Joint ultrasound examination not elsewhere classified
NK4XE (2001308469)
ispaghula (psylla seeds); oral
A06AC01 (21600555)
Endocrinology
46 (38004485)
Knee symptom/complaint
L15 (2002000639)
Tinnitus
H93.1 (45543152)
Connective tissue diseases, rheumatoid arthritis and comparable disease
202 (2001600200)
Essential (primary) hypertension
I10 (45591453)
Type 2 diabetes mellitus
E11 (45571656)
Blood type and Crossmatch panel - Blood
34531-4 (3044640)
amlodipine; oral
C08CA01 (21601747)
Hemoglobin [Mass/volume] in Blood
718-7 (3000963)
Diabetes non-insulin dependent
T90 (2002001131)
Leukocytes [#/volume] in Blood
26464-8 (3010813)
Apolipoprotein A-I [Mass/volume] in Serum or Plasma
1869-7 (3008364)
Erythrocytes [#/volume] in Blood
26453-1 (3026361)
Platelets [#/volume] in Blood
26515-7 (3007461)
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 (3016771)
MCV [Entitic mean volume] in Red Blood Cells
30428-7 (3024731)
MCH [Entitic mass]
28539-5 (3035941)
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 (3009542)
Apolipoprotein B/Apolipoprotein A-I [Percentile]
9340-1 (3011831)
paracetamol; oral, parenteral, rectal
N02BE01 (21604344)
tetanus toxoid, combinations with diphtheria toxoid
J07AM51 (21601317)
tramadol; oral, parenteral, rectal
N02AX02 (21604298)
diclofenac; oral, parenteral, rectal
M01AB05 (21603945)
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 (3003338)
Normoblasts [#/volume] in Blood
715-3 (3021589)
SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
94500-6 (706163)
Pain localized to other parts of lower abdomen
R10.3 (45534426)
Protein [Presence] in Urine by Test strip
20454-5 (3014051)
Diabetes, non-insulin-treated
215 (2001600211)
Bacteria [#/volume] in Urine by Automated count
51480-2 (3031040)
simvastatin; oral
C10AA01 (21601856)
Magnesium [Moles/volume] in Serum or Plasma
2601-3 (3012095)
ramipril; oral
C09AA05 (21601789)
INR in Blood by Coagulation assay
34714-6 (3032080)